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Genomic studies in African populations provide unique opportunities to understand disease 
aetiology, human genetic diversity and population history in a regional and a global context. In the 
largest study of its kind to date, comprising genome-wide data from 6,400 individuals from rural 
Uganda, and including whole-genome sequence from 1,978 individuals, we find evidence of 
geographically correlated fine-scale substructure, as well as complex admixture from eastern African 
hunter-gatherer and Eurasian populations. Examining 34 cardiometabolic traits, we demonstrate 
systematic differences in trait heritability between European and African populations, probably 
reflecting the differential impact of genetic and environmental factors on traits. In the first multi-
trait pan-African GWAS, we identify 12 novel loci associated with anthropometric, liver, 
haematological, lipid and glycemic traits. Our findings suggest that several functionally important 
signals at known and novel loci may be driven by differentiated variants within and specific to Africa, 
influencing reproducibility of associations signals across populations; these findings have important 
implications for the design of medical genetics research in Africa and globally.  We highlight the 
value of the largest sequence panel from Africa to date as a global resource for population genetics, 
imputation and understanding the mutational spectrum and its clinical relevance in African 
populations. Alongside phenotype data, we provide a rich new genomic resource for researchers in 




Africa is central to our understanding of human origins, genetic diversity and disease susceptibility.1 
The marked genomic diversity and allelic differentiation among populations in Africa, in combination 
with the substantially lower linkage disequilibrium (correlation) among genetic variants, has the 
potential to provide new opportunities to understand disease aetiology relevant to African populations 
but also globally.1,2 Consequently, there is a clear scientific and public health need to develop large-
scale efforts that examine disease susceptibility across diverse populations within the African 
continent. Such efforts will need to be fully integrated with research-capacity-building initiatives across 
the region.3  
 
Countries in Africa are undergoing epidemiological transitions—with a high burden of endemic 
infectious disease and growing prevalence of non-communicable diseases.4 Importantly, because of 
varying environments, population history and demography, and adaptive evolution, the spectrum and 
distribution of risk factors for a broad range of cardiometabolic and infectious diseases, and their 
individual contribution, may differ among populations globally.5 The study of population specific 
genetic variation and differences in allelic frequencies among populations, due to either selection or 
genetic drift, provides a distinct approach to identify novel disease susceptibility loci. However, despite 
the value of conducting such studies in Africa, there have been relatively few investigations of 
population diversity or the genetic determinants of cardiometabolic or infectious traits and diseases 
across the region.  
 
To conduct genetic studies in diverse populations across Africa, appropriate study designs that take 
into account population structure, admixture and genetic relatedness (overt and cryptic), as well as the 
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development of genetic tools to capture variation in African genomes, are needed.2 To leverage the 
relative benefits of different strategies, we undertook a combined approach of genotyping and low 
coverage whole-genome sequencing (WGS) in a population-based study of 6,400 individuals from a 
geographically defined rural community in South-West Uganda (Figure 1a, Supplementary Information 
1.0, Supplementary Figures 1-5 and Supplementary Tables 1-2). We present data from 4,778 
individuals with genotypes for ~2.2 million SNPs from the Uganda genome-wide association study 
(UGWAS) resource (Supplementary Information 1.1-1.3), and sequence data (Supplementary 
Information 1.4, Supplementary Figures 2-4) on up to 1,978 individuals spanning 41.5M SNPs and 
4.5M indels (UG2G) ; 343 individuals overlap between the two datasets (Figure 2 and Supplementary 
Information 1.4). Collectively, these data represent the Uganda Genome Resource (UGR). To enhance 
discovery, we also include collective data on up to 14,126 individuals from across the African continent 
for genome wide association analysis (Supplementary Information 4.0).   
 
Using these resources, we conducted a series of analyses to: 1) understand the population structure 
and demographic history in a geographically-defined population from Uganda (Supplementary 
Information 2.0); 2) refine estimates of heritability of 34 complex traits, accounting for environmental 
correlation among individuals (Supplementary Information 3.0); 3) assess the spectrum of genetic 
variants associated with cardiometabolic and other complex traits in populations from sub-Saharan 
Africa (Supplementary Information 4.0); 4) describe the spectrum of disease-causing mutations in the 
UG2G cohort (Supplementary Information 5.0); and ) highlight the value of the UG2G sequence panel 
as an imputation resource (Supplementary Information 5.0). Importantly, the UGR was designed to 
help develop local resources for public health and genomic research, including building research 
capacity, training and collaboration across the region. We envisage that data from these studies will 




Population structure and demographic history in a rural Ugandan community 
To help inform strategies that account for genetic diversity, and develop resources to reliably capture 
the broad allelic spectrum in a geographically-defined rural Ugandan community, we provide the first 
detailed description of genetic diversity and fine-scale structure among nine ethno-linguistic 
population groups from the UGR (Supplementary Information 2.0).  
 
Although the study population represents a geographically-defined rural community from the Kalungu 
District in South-West Uganda (Figure 1a), principal components (PC) inferred from fineSTRUCTURE 
showed evidence suggestive of population substructure (Figure 1b, Supplementary Information 2.0 
and Supplementary Figures 5-14, Supplementary Table 3), with clines along PC1 and PC2 being highly 
correlated with Eurasian and East African Nilo-Saharan ancestry, respectively (Supplementary Figures 
10-12 and Supplementary Information 2.2.2). Using fineSTRUCTURE6 and Procrustes analyses, we 
show for the first time that substructure among ethno-linguisitic groups in a rural Ugandan community 
is correlated with their historical geographical origins (Supplementary Tables 4-6, Supplementary 
Figures 13-17). Populations from the central region of Uganda (the Baganda, Basoga and Batooro), 
migrant populations from Rwanda, Burundi, Tanzania and those from South-western Uganda (Bakiga, 
Banyankole and Bafumbira) form separate clades (Supplementary Information 2.2-2.3, 
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Supplementary Figure 5 and Supplementary Figures 13-14). This is consistent with recent patterns of 
population migration into Uganda from neighbouring regions and border countries, including from 
Rwanda and Burundi (Supplementary Information 2.1).7  
 
PCA, unsupervised ADMIXTURE, and fineSTRUCTURE analysis were suggestive of broad Eurasian and 
hunter-gatherer admixture across ethno-linguistic groups (Figures 1c-d, Supplementary Information 
2.0, Supplementary Figures 18-24) We use multiple lines of evidence, including formal tests for 
admixture (f3, f4 tests, MALDER),8 6 the double conditioned site frequency spectrum, and the 
distribution of mitochondrial and Y chromosome haplogroups to identify Eurasian gene flow in Uganda 
(Supplementary Tables 9-22, Supplementary Figures 25-30 and Supplementary Information 2.4.2-
2.4.7). Using the Conditional Random Field model (CRF), we show strong evidence of Neanderthal 
ancestry in Uganda, providing strong evidence of Eurasian admixture resulting from back to Africa 
migration. (Supplementary Table 15 and Supplementary Information 2.4.5). Our findings suggest that 
the patterns and extent of this admixture varied among these regional populations.  We show evidence 
of extensive Eurasian admixture across all populations with multiple events ranging between 200 and 
9,000 years ago (ya), consistent with back migration into Africa9 10(Figure 1d and Supplementary 
Information 2.4.2-2.4.7). We also observed novel widespread hunter-gatherer admixture in Uganda, 
including strong admixture signals from co-regional hunter-gatherer populations such as the rainforest 
hunter-gatherers and Hadza (Figure 1c, Supplementary Information 2.4.3, 2.4.7, Supplementary 
Tables 10-11 and Supplementary Table 22). These signals were specific to the Ugandan and other East 
African populations (Figure 1e and Supplementary Table 11, Supplementary Table 22), and spanned 
between 2,400 and 4,500 ya (Figure 1d)—suggesting assimilation of hunter-gatherer ancestry through 
population migration events, including the Bantu expansion. We also provide direct evidence of the 
temporal shape of this ancient admixture, reflected by a relative excess of allele sharing with ancient 
Neolithic Europeans (both early European farmers11 and their Anatolian ancestors12), consistent with 
previous reports,9,13 and novel evidence for regionally specific shared ancestry with an ancient East 
African genome (Mota5) in the Ugandan populations (Supplementary Information 2.4.7 and 
Supplementary Tables 18-22). 
 
Using MSMC2 on high coverage genomes (Supplementary Information 2.5),14 we show that the 
Ugandan populations follow a similar demographic history to other Bantu speaking populations, with 
the Ugandan population split from Yoruba, Nigeria (YRI) ~11,500 ya, with ongoing gene flow between 
Uganda-LWK in recent times (Supplementary Information 2.5, Supplementary Tables 23-24, 
Supplementary Figures 31-35). The Uganda-YRI divergence is older than predicted by the Bantu 
expansion. 15 However, these differences could also reflect population differences, including varying 
patterns of Eurasian and regional admixture in East and West African populations. It also should be 
noted that these divergence times are lower bounds, and are likely to be affected by gene flow 
between these populations following divergence, as has been previously documented. 14 
 
We then explored recent population history by examining rare variant sharing between the Baganda 
and other populations; we examined variants occurring only twice in the entire dataset (designated f2) 
(Figure 1e and Supplementary Information 2.3). Dating haplotypes surrounding f2 variants can provide 
important information about the interrelation among populations, including ancient and recent 
population divergence.16 Using this approach, we find that f2 variants shared between European and 
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Ugandan populations are more recent than those shared between European and West African 
populations (median f2 dates were ~19,500 ya for Baganda compared with ~51,000 ya for YRI). This 
finding is consistent with back migration10 and Eurasian admixture in the Uganda populations 
(Supplementary Information 2.3, Supplementary Table 8 and Supplementary Figures 19-20).2,13 
Examining Ugandan populations in the context of other African populations, we find that f2 sharing 
between Ugandan populations and Ethiopians tend to be older (median f2 dating was ~23,000 ya) than 
Ugandan-West African splits, probably reflecting a combination of deeper population splits between 
Bantu- and Afro-Asiatic-speaking groups, and relatively high Eurasian admixture in the Ethiopian 
populations. We also find evidence of very ancient divergence (with a median f2 dating of ~29,000 ya) 
between Baganda and Zulu (Figure 1e and Supplementary Figure 20); this could reflect old f2 sharing 
with Khoe-San haplotypes present among Zulu and other Southern African populations. Our large 
African sequence resource allows the first such examination of shared rare variation among 
populations, and highlights the complex demographic histories of populations in this region.  
 
Heritability of cardiometabolic traits in a rural Ugandan community 
Narrow-sense heritability represents the fraction of phenotypic variation in a population that is due to 
additive genetic variation. As such, it represents an important metric determining the genetic basis of 
complex traits and diseases. However, heritability of complex traits in African populations is not 
known. We assessed heritability for 34 complex cardiometabolic traits using a newly developed mixed 
model approach that also models environmental correlation17 (Figure 3 and Supplementary 
Information 3.0). 
 
We found marked variation in heritability across traits in UGWAS (Figure 3, Supplementary 
Information 3.0 and Supplementary Table 25), and find clear statistical differences in heritability 
estimates for several traits, compared to European populations (Figure 3 and Supplementary Tables 
26-28). For example, the narrow-sense heritability for height was 49% in UGWAS, contrasting with 
estimates of 70-80% in European populations (p<0.0001) (Figure 3, Supplementary Tables 26-28). We 
speculate that these differences may be due to varying patterns of genetic loci influencing height or 
other traits in European and African populations, or perhaps more plausibly due to a larger proportion 
of environmental variation explaining phenotypic variance (e.g. under-nutrition in rural African 
populations may attenuate the effects of genetic variation on height).18 We also found evidence for 
statistical gene-environment interaction for waist-hip ratio, red blood cell distribution width and 
haematocrit (permutation p=<0.0001). These statistical interactions may represent interplay between 
genetic factors and dietary factors, iron stores and nutritional status (Supplementary Table 25). 
Reliable assessment of the interrelation between genetic and environmental variation, including 
specific environmental indices, will require application of these methods to much larger-scale studies 
with relevant phenotypic information. Examining locus-specific heritability would complement direct 
assessments of population differences in heritability of population traits. 
 
GWAS of cardiometabolic traits in African populations 
To assess the spectrum of genetic variants associated with cardiometabolic traits in African 
populations, we performed a GWAS of 34 cardiometabolic traits in up to 14,126 individuals from across 
the African continent, including populations from Ghana, Kenya, Nigeria, South Africa and Uganda 
(Supplementary Information 4.0, Supplementary Data Table 1, Figure 4 and Table 1). We also 
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undertook an exploration of analytical strategies for populations with marked genetic diversity and 
structure to inform GWAS design and analytical strategies in African populations (Supplementary 
Information 4.6-4.10, Supplementary Tables 31, Supplementary Figures 38-39). To maximise 
opportunities for genomic discovery, we meta-analysed GWAS data from all study populations using 
the Han-Eskin random-effect meta-analytic approach implemented in METASOFT19 (Supplementary 
Information 4.8). We first re-assessed thresholds for genome-wide statistical significance in African 
populations using several approaches20-23 and found that a statistical threshold of 5.0 x 10-9 is more 
relevant in populations with high genetic diversity and relatively lower levels of LD (Supplementary 
Information 4.9-4.10). In our discovery meta-analysis, we identified 41 distinct association signals at 
this new genome-wide statistical threshold for at least one trait (Supplementary Information 4.13, 
Supplementary Data Table 1, Supplementary Figures 40-66, Supplementary Tables 32-39 ). More than 
half of these distinct association signals (23/41) were attributable to genetic variants specific to African 
populations (monomorphic or extremely rare in Europeans) (Supplementary Information 4.13 and 
Supplementary Data Table 1), including new distinct signals at previously identified loci (Table 1). 
Twelve association signals were novel loci—trait assocations, including for liver function traits, 
anthropometric indices, HbA1c, and heamatological and blood cell traits (Table 1, Figure 4 and 
Supplementary Data Table 1) . We note that most novel discovery was driven by low frequency (0-5% 
MAF) variants; ten of these 12 novel association signals were low frequency or monomorphic 
(MAF<2%) in European populations (Supplementary Data Table 1). Our findings demonstrate the 
potential for novel discovery in African GWAS. Collectively, these findings provide the first empirical 
evidence to support theoretical models that suggest that power for discovery increases in meta-
analyses of ethnically diverse populations, specifically driven by increased detection of low frequency 
and population-specific novel associations.24  
 
Our novel association signals included a functionally relevant association between a 3.8Kb deletion (-
α3.7), known to cause alpha thalassemia, and HbA1C levels at p = 2.5-17 (Supplementary Information 
4.13, Table 1 and Figure 4). The -α3.7 variant is thought to have risen to high frequencies in African 
populations in regions endemic for malaria by virtue of providing resistance to severe malaria.25 Our 
findings recapitulate the need to more fully understand functional variation, including for 
heamoglobinopathies, that may explain a substantial proportion of variation in HbA1c in African 
populations, as they may have a direct impact on the utility of using HbA1C as a clinical tool for 
detection and diagnosis of diabetes in Africa.26 We also discovered an association signal at the 
glutamate-pyruvate transaminase (GPT) locus with the liver function biomarker amino-transferase 
(ALT), p = 5.7-38 (Supplementary Information 4.13, Table 1 and Figure 4). The lead SNP was African 
population-specific variant lying in a GPT splice site region. GPT is the gene primary responsible for the 
production of the ALT enzyme, highlighting the biological relevance of this association signal. 
 
Notably, we found limited reproducibility among several functionally important known and novel loci 
in our meta-analysis (e.g. the DARC locus associated with monocyte count). Some of these associations 
appear to be driven by population specific rare or low frequency variants (Supplementary Information 
4.13 and Supplementary Data Table 2). We also found evidence of statistical heterogeneity of effect in 
associations with several traits (Supplementary Information 4.13, Supplementary Data Table 1 and 
Supplementary Data Table 2); this was found to arise from differences in LD structure around causal or 
lead variants or presence of multiple distinct variants at the locus (alleleic heterogeneity), providing 
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important insights into the genetic architecture of traits (Supplementary Information 4.13). Given high 
genetic diversity, and regionally specific patterns of admixture, we highlight the need to design GWAS 
studies to account for these differences in allele frequency spectrum, and LD patterns across the 
African cohorts. With caveats for rare variant discovery in some scenarios (Supplementary Information 
4.13), our analyses emphasize the value of utilizing diverse populations across the region—to maximise 
opportunities for genomic discovery in the region.  
 
 
A whole genome resource for population and medical genetics 
With the largest whole genome sequence dataset from Africa to date (Figure 2 and Supplementary 
Information 5.0), with nearly a quarter of all variants being novel relative to currently available 
genome sequence data, we present a unique resource to examine the spectrum of human genetic 
diversity in Africa, regional and global population history, and the phenotypic consequences of putative 
functional variants among individuals, as well as a resource to facilitate medical genetics studies in the 
region.  
 
As expected, and consistent with the out-of-Africa model, Africans carry the largest number of variants, 
the overwhelming majority being rare (Supplementary Information 5.0, Supplementary Tables 40-41, 
Supplementary Figures 67-70). In line with these observations, African populations provide greater 
opportunities for variant discovery as a function of sample size (Supplementary Information 5.3 and 
Supplementary Figure 71). We identified 9.5 M novel variants in the UG2G resource that are not 
present in the 1000G Phase 3, AGVP and UK10K data (Figure 2), highlighting the importance of 
assessing diverse populations on a larger scale. 
 
We also explored the putative functional consequences of variation in the UG2G population 
(Supplementary Information 5.4, Supplementary Figures 72-75, Supplementary Tables 42-43). 
Consistent with overall diversity, UG2G participants carried more missense variants per individual 
compared with the UK10K population (12,198 and 10,153 variants/individual respectively). However, 
missense variants formed a greater proportion of all variation among Europeans. (Supplementary 
Figure 72). For disease-causing mutations (DMs), as annotated by the HGMD (Supplementary 
Information 5.4 and Supplementary Figures 73-74), we identified a median of 29 DMs/individual in 
our cohort compared to 25 DMs/individual in UK10K, despite more extensive studies in European 
populations, and potentially biased ascertainment.27 By contrast, in UG2G, we observed a median of 3 
homozygous DMs/individual compared with to 4 homozygous DMs/individual in UK10K 
(Supplementary Information 5.4) (p<2X10-16). The distribution of the mutational spectrum in African 
and European populations is consistent with previous reports, 28,29 and the impact of differences in 
demographic history among these populations (an evolutionary bottleneck in European populations 
with subsequent drift).28  
 
Allelic frequency differences between populations along with clinical phenotype data may provide 
insights into the functional relevance of putative DMs. On assessing 47 DMs that were common in our 
cohort (MAF>5%) but rare or absent in the UK10K data (Supplementary Table 43),30 we identified 
established causal loci associated with haematological traits, such as the G6PD and sickle cell variants 
(HBB), which are common in UG2G, but absent from the UK10K data, consistent with these loci being 
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under positive or balancing selection and protective against malaria (Supplementary Table 43). 
However, we also show that several putative DMs that are common in UG2G but rare in UK10K show 
no strong evidence for association with relevant cardiometabolic traits, indicating that they are unlikely 
to be disease-causing or have different or lower penetrance within African populations due to complex 
factors, including epistasis, or gene-environment interplay (Supplementary Figure 75). This emphasises 
the need to carefully evaluate the impact of putative functional or disease-causing mutations because 
they may not have any clinical or biological relevance, or be readily transferable across populations.27,31 
 
Finally, we assess the impact of the addition of the UG2G panel to existing reference panels on 
imputation accuracy among populations from Sub-Saharan Africa (Supplementary Information 5.5). 
We show that addition of the UG2G panel to existing sequence panels with African haplotypes, such as 
the 1000 Genomes Phase 3 panel, and the African genome variation sequence panel (combined 
n=3,895), markedly improved imputation accuracy (r2 increase by 0.08 (MAF<=0.01) and 0.04 (all MAF)) 
for rare and common variants in Ugandan populations (Figure 5, Supplementary Figure 76 and 
Supplementary Information 5.4). Additionally, we observe a substantial increase in imputation 
accuracy across the allele frequency spectrum generally in East African populations, including Nilo-
Saharan linguistic groups such as the Kalenjin (Figure 5), probably reflecting haplotype sharing across 
the region. The number of variants successfully imputed (info0.3) substantially increased using the 
UG2G panel in comparison with the 1000 Genomes phase III and AGVP combined panels, with an 
additional 8M variants being accurately imputed in Baganda, and 1.5M additional variants imputed 
accurately among other East African populations (Figure 5). This resource coupled with current 
initiatives to generate very large reference panels (e.g. the Haplotype Consortium32) has important 




We demonstrate the value of cataloging whole-genome sequence variation and undertaking GWAS of 
cardiometabolic traits in a geographically-defined rural community in south-west Uganda. The Uganda 
Genome Project datasets provide rich genomic resources for studies of human population history and 
genome-wide association studies, and provide a mechanism to evaluate the clinical relevance of 
genetic diversity both in African populations and globally.  
 
We present evidence for fine-scale structure and admixture in this Ugandan community, reflecting 
complex ancient and recent population migrations and expansions in East Africa. Our findings highlight 
the need for larger-scale deep sequencing, including a systematic assessment of hunter-gatherer 
populations across Africa, to more fully understand the genetic history and diversity of Africa. 
Sequencing of DNA from ancient skeletal material across Africa will greatly facilitate such efforts33—
allowing stronger inferences into the source of genetic diversity and population history in Africa and 
globally. 
 
Accounting for environmental correlation, we describe statistical differences in heritability for traits 
between African and European populations; these may be suggestive of differences in the interplay 
between genetic and environmental effects on heritable traits, as well as the impact of differences in 
genetic architecture as a result of selection, drift and historical demographic events. Our findings re-
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iterate the dynamic and context-specific nature of heritability, potentially varying among populations, 
demographic factors and environmental exposures.34  
 
Our identification of several novel susceptibility loci across a range of complex traits argues for scaling 
efforts in the region. The continental and population-specificity of a large proportion of these 
association signals suggests that inclusion of diverse populations across Africa in GWAS may have the 
greatest potential for discovery of novel targets. Furthermore, understanding differences in 
heritability, and identifying the full spectrum of genetic variation associated with complex traits and 
diseases across Africa, will require much larger-scale prospective studies that should include rich 
genomic and phenotypic data for complex traits and diseases, as well as information on environmental 
factors. In these contexts, our results provide a framework for undertaking more extensive GWAS in 
populations from Africa. 
 
Since genetic diversity is greatest in African populations, including a substantial proportion of genetic 
variation that is continentally and regionally distinct, it will be critical to understand the functional and 
biological relevance of this diversity. This has global implications. Understanding the biological basis for 
population-specific association signals, as well as the impact and tranferability of putatively functional 
and disease causing mutations at the individual and population level, will require representative 
genomic resources—emphasizing the need for the parallel development of transcriptomic and cellular 
biological resources at the population level that reflect global human diversity.35 
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